
InVirtuoLabs Nets €2.85M to Revolutionize Drug Discovery with AI Precision
A beacon of innovation has emerged from the serene shores of Lugano, as InVirtuoLabs secures €2.85 million in its inaugural funding round. This Swiss biotech pioneer, dedicated to reshaping the future of pharmaceuticals, is set to harness artificial intelligence to slash the staggering costs and timelines that have long burdened drug development. With this capital,…